Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0HAV stock hub

LON/0HAV has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0HAVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

24B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0HAV

In the news

Latest news · LON/0HAV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.8

P25 12.9P50 16.9P75 23.5

Trailing P/E25.5

P25 15.9P50 22.9P75 35.8

ROE19.9

P25 -54.2P50 2.1P75 13.7

ROIC17.7

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0HAV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

232

Groups with data

Currency

USD

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	18,000
Employees Change	100%
Employees Change Percent	0.56
Enterprise value	$25.3B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US00846U1016
Last refreshed	2026-05-10
Market cap	$24B
Price	$116
Price currency	USD
Rev Per Employee	286,097.18x
Sector	Healthcare
Sic	3826
Symbol	lon/0HAV
Website	https://www.agilent.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.92%
EV Earnings	26.9x
EV/EBIT	20.42x
EV/EBITDA	17.06x
EV/FCF	34.95x
EV/Sales	4.88x
FCF yield	3.02%
Forward P/E	18.8x
P/B ratio	4.76x
P/E ratio	25.5x
P/S ratio	4.66x
PE Ratio10 Y	37.4x
PE Ratio3 Y	29.65x
PE Ratio5 Y	32.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.89%
EBITDA Margin	27.9%
FCF margin	14.06%
Gross margin	52.3%
Gross Profit	$2.7B
Gross Profit Growth	4.79%
Gross Profit Growth Q	5.78%
Gross Profit Growth3 Y	-0.76%
Gross Profit Growth5 Y	4.59%
Net Income	$940.3M
Net Income Growth	2.46%
Net Income Growth Q	-4.09%
Net Income Growth Years	0%
Net Income Growth3 Y	-0.84%
Net Income Growth5 Y	9.75%
Pretax Margin	20.27%
Profit Margin	18.26%
Profit Per Employee	$52,239
Profitable Years	16
ROA	8.53
Roa5y	8.87
ROCE	15.96
ROE	19.95
Roe5y	22.37
ROIC	17.69
Roic5y	18.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	9.69%
Cagr3y	-3.67%
Cagr5y	-2.28%
Div CAGR3	0.85%
Div CAGR5	5.65%
EPS Growth	3.94
EPS Growth Q	-3.6
EPS Growth Years	0
EPS Growth3 Y	0.67
EPS Growth5 Y	11.77
FCF Growth	-24.31%
FCF Growth Q	-47.61%
FCF Growth3 Y	-2.18%
FCF Growth5 Y	-1.88%
OCF Growth	-17.74%
OCF Growth Q	-37.82%
OCF Growth10 Y	8.06%
OCF Growth3 Y	1.05%
OCF Growth5 Y	2.77%
Revenue Growth	8.14x
Revenue Growth Q	6.96x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	0.65x
Revenue Growth5 Y	5.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.57
Assets	$9.3B
Cash	$1.3B
Current Assets	$3.4B
Current Liabilities	$1.6B
Debt	$2.6B
Debt EBITDA	$1.76
Debt Equity	$0.51
Debt FCF	$3.58
Equity	$5B
Interest Coverage	15.49
Liabilities	$4.3B
Long Term Assets	$6B
Long Term Liabilities	$2.7B
Net Cash	$-1.3B
Net Cash By Market Cap	$-5.45
Net Debt EBITDA	$0.91
Net Debt Equity	$0.26
Net Debt FCF	$1.8
Tangible Book Value	$1.5B
Tangible Book Value Per Share	$5.15
WACC	10.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.07
Inventory Turnover	3.28
Net Working Capital	$675.7M
Quick ratio	1.47
Working Capital	$1.7B
Working Capital Turnover	$2.23

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.73%
Dividend Growth	-0.85%
Dividend Growth Years	0%
Dividend per share	$0.75
Dividend Years	10
Dividend Yield	0.65%
Ex Div Date	2026-03-31
Last Dividend	$0.19
Payout Frequency	Quarterly
Payout Ratio	21.94%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	9.68%
200-day SMA	129.5
3Y total return	-10.61%
50-day SMA	115.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-10.91%
All Time High	179.3
All Time High Change	-35.46%
All Time High Date	2021-09-07
All Time Low	61.15
All Time Low Change	89.22%
All Time Low Date	2018-07-05
ATR	4.69
Beta	1.22
Ch YTD	-15.47
High	120.4
High52	161.6
High52 Date	2025-11-26
High52ch	-28.38%
Low	113.5
Low52	107.3
Low52 Date	2025-05-09
Low52ch	7.83%
Ma50ch	-0.07%
Price vs 200-day SMA	-10.67%
RSI	48.94
RSI Monthly	44.25
RSI Weekly	41.48
Sharpe ratio	0.26x
Sortino ratio	0.56
Total Return	2.38%
Tr YTD	-15.12
Tr1m	1.16%
Tr1w	1.26%
Tr3m	-11.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$1.2B
Operating Income Growth	5.7
Operating Income Growth Q	5.12
Operating Income Growth3 Y	-0.66
Operating Income Growth5 Y	7.94
Operating margin	23.89

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	281,644,144%
Net Borrowing	-11,736,224
Shares Insiders	0.25%
Shares Institutions	92.2%
Shares Qo Q	0%
Shares Yo Y	-1.73%
Short Ratio	1.97

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$629.8M
Average Volume	1,203.7x
Bv Per Share	17.81
CAPEX	$-293.8M
Ch1m	1.16
Ch1w	1.26
Ch1y	8.79
Ch3m	-11.45
Ch3y	-12.62
Ch5y	-13.96
Ch6m	-20.29
Change	-2.13%
Change From Open	-3.91
Close	118.2
Days Gap	1.85
Depreciation Amortization	207,584,462
Dollar Volume	28,695.4
Earnings Date	2026-05-27
EBIT	$1.2B
EBITDA	$1.4B
EPS	$3.3
F Score	5
FCF	$723.8M
FCF EV Yield	2.86x
Financing CF	-551,784,870
Fiscal Year End	October
Founded	1,999
Goodwill	3,289,076,776
Graham Number	49.8038
Graham Upside	-56.96
Income Tax	$103.5M
Investing CF	-286,461,630
Is Primary Listing	0
Last Earnings Date	2026-02-25
Last Report Date	2026-01-31
Lynch Fair Value	$44.26
Lynch Upside	-61.75
Ma150	132.2
Ma150ch	-12.5%
Ma20	117.2
Ma20ch	-1.26%
Net CF	211,383,900
Next Earnings Date	2026-05-27
Open	120.4
P FCF Ratio	33.13
P OCF Ratio	23.57
Payment Date	2026-04-22
Position In Range	32.38
Ppne	1,662,876,238
Price Date	2026-05-08
Price EBITDA	$16.69
Ptbv Ratio	16.47
Relative Volume	0.21x
Revenue	5,149,749,150x
SBC By Revenue	1.83x
Share Based Comp	94,029,390
Tax By Revenue	2.01x
Tax Rate	9.92%
Tr6m	-19.97%
Volume	248
Z Score	5.04

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0HAV dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.6%

$0.75 annual per share

Payout ratio

+21.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.7%

0 consecutive years of growth

Total shareholder yield

+2.4%

Next ex-dividend date: 2026-03-31

Performance

LON/0HAV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0HAV?

Insider, institutional, and short-interest positioning.

Institutional ownership

+92.2%

Share of float held by funds and institutions

Insider ownership

+0.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0HAV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.9

Neutral momentum band

Price vs 200-day MA

-10.7%

50/200-day relationship not available

Beta (5Y)

1.22

More volatile than the market

Sharpe ratio

0.26

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0HAV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0HAV stock rating?

lon/0HAV is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0HAV analysis?

The full report lives at /stocks/lon/0HAV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0HAV?

The latest report frames lon/0HAV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0HAV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.